{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T10:46:21Z","timestamp":1792320381909,"version":"4.4.0"},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Ophthalmol"],"published-print":{"date-parts":[[2014]]},"DOI":"10.4103\/0301-4738.118451","type":"journal-article","created":{"date-parts":[[2014,5,8]],"date-time":"2014-05-08T03:33:46Z","timestamp":1399520026000},"page":"497","source":"Crossref","is-referenced-by-count":34,"title":["Linezolid-induced optic neuropathy"],"prefix":"10.4103","volume":"62","author":[{"given":"Divya","family":"Karuppannasamy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andavar","family":"Raghuram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devisundaram","family":"Sundar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0301-4738.118451-1","first-page":"1111","volume-title":"Linezolid-induced inhibition of mitochondrial protein synthesis","author":"De","year":"2006","journal-title":"Clin Infect Dis"},{"key":"key-10.4103\/0301-4738.118451-2","first-page":"1189","volume-title":"Linezolid- associated peripheral and optic neuropathy, lactic acidosis and serotonin syndrome","author":"Narita","year":"2007","journal-title":"Pharmacotherapy"},{"key":"key-10.4103\/0301-4738.118451-3","unstructured":"Zyvox (linezolid) product information. Rydalmere, NSW: Pharmacia Australia; 2002."},{"key":"key-10.4103\/0301-4738.118451-4","first-page":"111","volume-title":"Linezolid-induced optic neuropathy: A mitochondrial disorder?","author":"Javaheri","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0301-4738.118451-5","first-page":"402","volume-title":"Complete blindness after optic neuropathy induced by short-term linezolid treatment in a patient suffering from muscle dystrophy","author":"Azamfirei","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"key-10.4103\/0301-4738.118451-6","first-page":"e73","volume-title":"A case of optic neuropathy after short-term linezolid use in a patient with acute lymphatic leukemia","author":"Joshi","year":"2009","journal-title":"Clin Infect Dis"},{"key":"key-10.4103\/0301-4738.118451-7","first-page":"528","volume-title":"Peripheral neuropathy associated with prolonged use of linezolid","author":"Bressler","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"key-10.4103\/0301-4738.118451-8","unstructured":"World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis. Available from: http:\/\/www.who.int\/entity\/tb\/publications\/2006\/who_htm_tb_2008_402.pdf.[last accessed on 2012 June 12]."},{"key":"key-10.4103\/0301-4738.118451-9","first-page":"387","volume-title":"A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug- resistant tuberculosis","author":"Migliori","year":"2009","journal-title":"Eur Respir J"}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:23:49Z","timestamp":1786649029000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0301-4738.118451"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":9,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014]]}},"alternative-id":["118451"],"URL":"https:\/\/doi.org\/10.4103\/0301-4738.118451","relation":{},"ISSN":["0301-4738"],"issn-type":[{"value":"0301-4738","type":"print"}],"subject":[],"published":{"date-parts":[[2014]]}}}